<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pancreas-kidney transplantation in diabetes mellitus: Benefits and complications</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pancreas-kidney transplantation in diabetes mellitus: Benefits and complications</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pancreas-kidney transplantation in diabetes mellitus: Benefits and complications</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tarek Alhamad, MD, MS, FACP, FASN</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert J Stratta, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel C Brennan, MD, FACP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David M Nathan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Albert Q Lam, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 20, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Simultaneous pancreas-kidney (SPK) transplantation is an established treatment for selected patients with insulin-requiring diabetes with either advanced chronic kidney disease (CKD) or end-stage kidney disease (ESKD). In the United States, nearly 90 percent of pancreas transplants are performed as SPK transplants, with the remainder performed as sequential pancreas after kidney (PAK) transplants or pancreas transplants alone (PTA) [<a href="#rid1">1,2</a>]. The vast majority of SPK, PAK, and PTA transplants are performed in patients with type 1 diabetes, although some programs offer such transplants to insulin-using patients with type 2 diabetes.</p><p>While SPK transplantation usually employs grafts procured from a single deceased donor, PAK typically involves transplantation of a deceased-donor pancreas graft into a recipient with either a functioning living- (most common) or deceased-donor kidney allograft. Selected patients without substantial kidney disease may be candidates for PTA.</p><p>The benefits and nonimmunologic complications associated with either SPK or PAK transplantation in patients with diabetes mellitus are presented here. Patient selection for and the clinical approach to these procedures are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7305.html" rel="external">"Pancreas-kidney transplantation in diabetes mellitus: Patient selection and pretransplant evaluation"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/118566.html" rel="external">"Pancreas-kidney transplantation in diabetes mellitus: Surgical considerations and immunosuppression"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">BENEFITS</span><span class="headingEndMark"> — </span>The major benefits of simultaneous pancreas-kidney (SPK) transplantation are decreased mortality and improved quality of life. The decreased mortality is due in large part to the well-established survival benefit conferred by kidney transplantation alone (KTA; even without pancreas transplantation) compared with dialysis [<a href="#rid3">3</a>]. However, adding a pancreas to a kidney transplant, either simultaneously or sequentially, may be associated with an incremental survival benefit beyond KTA compared with dialysis [<a href="#rid4">4-15</a>]. This finding remains true even in the setting of early pancreas graft loss [<a href="#rid16">16,17</a>]. (See  <a class="medical medical_review" href="/z/d/html/7347.html" rel="external">"Kidney transplantation in adults: Patient survival after kidney transplantation", section on 'Survival compared with dialysis'</a>.)</p><p>The improved quality of life is due to freedom from frequent blood sugar monitoring, insulin therapy, glucose variability, and dialysis [<a href="#rid7">7,18-30</a>]. Although both SPK and KTA are associated with an increased energy level and better overall functional status, SPK transplant recipients experience additional improvements in sense of well-being, autonomy, and independence. By rendering an individual "ex-diabetic," a functioning pancreas transplant removes the stigma of diabetes by eliminating fear of hypoglycemia, promoting fewer dietary restrictions, and providing opportunities for improved lifestyle change and incremental gains in quality-adjusted life years [<a href="#rid7">7,22-28,31-34</a>].</p><p>Our understanding of the relative benefits of SPK compared with KTA is hampered by the absence of any randomized trials. All of the claims regarding the benefits of pancreas transplantation are based upon limited and generally poorly controlled studies. SPK transplantation, by achieving euglycemia, should theoretically decrease the long-term retinal, kidney, neurologic, and macrovascular complications of diabetes. However, no randomized trials have been performed, and studies of secondary complications of diabetes must be interpreted in light of the fact that most patients undergoing pancreas transplantation have had diabetes for well over two decades and often have advanced-stage complications that may be irreversible. The majority of studies examining the effects of pancreas transplantation on the secondary complications of diabetes are older, inadequately powered, and/or lack appropriate control groups [<a href="#rid35">35-43</a>].</p><p>The majority of patients who undergo SPK transplantation have type 1 diabetes. However, the procedure may also confer benefits for selected patients with type 2 diabetes [<a href="#rid44">44-49</a>].</p><p>Survival rates after SPK transplantation are comparable between patients with types 1 and 2 diabetes when adjusted for other risk factors [<a href="#rid39">39,40,44,45,47,49-52</a>]. An analysis of data obtained from the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) showed no difference between patients with types 1 and 2 diabetes in the rate of death or kidney or pancreas failure once adjustments for age, race, body weight, dialysis time, and cardiovascular comorbidities were made. Numerous other single-center studies have corroborated these findings. A Scientific Registry of Transplant Recipients (SRTR) study demonstrated that, in patients with type 2 diabetes undergoing SPK transplantation, having a functioning pancreas allograft at three months (94 percent of patients) conferred a survival advantage for SPK transplantation compared with either living-donor or deceased-donor KTA [<a href="#rid53">53</a>].</p><p class="headingAnchor" id="H100158167"><span class="h2">Patient survival</span><span class="headingEndMark"> — </span>Survival for SPK transplant recipients is much better than that of waitlisted patients who continue to receive dialysis [<a href="#rid4">4-13,54,55</a>]. In a retrospective review of 351 patients on dialysis with type 1 diabetes, at seven years, survival rates were higher among 130 who underwent SPK transplantation compared with 190 who remained on the waiting list (77 versus 40 percent, respectively) [<a href="#rid55">55</a>]. Cardiovascular risk factors, hypertension, and other clinical characteristics were similar between groups. However, it is well established that patients who undergo KTA have improved survival compared with those who are eligible for transplantation but remain on the waiting list. In addition, a number of studies have reported that the contribution of the pancreas transplant adds to the mortality benefit of KTA for patients with diabetes. (See  <a class="medical medical_review" href="/z/d/html/7347.html" rel="external">"Kidney transplantation in adults: Patient survival after kidney transplantation", section on 'Survival compared with dialysis'</a>.)</p><p>Among patients with type 1 diabetes, SPK transplantation appears to confer better survival than KTA, at least when compared with deceased-donor KTA [<a href="#rid55">55-65</a>]. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>A small, 10-year study evaluated outcomes after SPK transplantation in 14 patients with type 1 diabetes and end-stage diabetic nephropathy versus 15 diabetics subjected to deceased-donor KTA [<a href="#rid62">62</a>]. Ten-year mortality was significantly lower among those who underwent SPK transplantation (20 versus 80 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective study of 18,549 patients with type 1 diabetes reported that the eight-year survival rate was similar for SPK (72 percent) and living-donor kidney recipients (72 percent) but higher than that observed for deceased-donor kidney recipients (55 percent) [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patient survival was evaluated among 130, 379, and 296 recipients of living-related-donor kidneys, SPKs, and deceased-donor kidneys, respectively [<a href="#rid63">63</a>]. Patient survival was significantly lower for the deceased-donor KTA group versus that observed with recipients of SPK and living-related-donor KTAs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a nationwide cohort of kidney replacement therapy in patients with type 1 diabetes with 30-year follow-up from the Netherlands, SPK transplant recipients with a functioning graft at one year (91 percent) had the longest survival (median 17.4 years) compared with either deceased-donor or living-donor KTA recipients [<a href="#rid4">4</a>]. The 10- and 20-year mortality hazard ratios (HR) favoring SPK over KTA were 0.56 and 0.69, respectively.</p><p></p><p>It is less clear whether SPK transplantation has any benefit over KTA from a living donor. In some, but not all, studies, SPK transplantation is associated with better survival compared with KTA from a living donor. The potentially superior benefit gained by SPK versus living-donor KTA generally depends upon the early function of the pancreas allograft. SPK recipients who have good pancreas function early on tend to do better than living-donor KTA recipients. This was shown in an analysis of OPTN/UNOS registry data [<a href="#rid66">66</a>]. At 72 months, patient survival was similar between SPK and living-donor KTA (84 versus 80 percent at 72 months, respectively). After adjusting for multiple variables, compared with SPK recipients, living-donor KTA recipients had a lower risk of graft failure (HR 0.71, 95% CI 0.61-0.83) and patient death (HR 0.78, 95% CI 0.65-0.94).</p><p>However, in a more detailed analysis of the same data in which SPK recipients were stratified based upon a functioning pancreas allograft at one year, patient survival at 84 months posttransplant was highest in SPK recipients with a functioning pancreas graft 12 months posttransplant, followed by living-donor KTA, SPK recipients with a nonfunctioning pancreas, and then deceased-donor KTA (89, 80, 74, and 65 percent, respectively) [<a href="#rid67">67</a>]. Kidney allograft survival was also highest in SPK recipients with a functioning pancreas.</p><p>Some patients receive a living-donor KTA as the first option and then subsequently receive a pancreas after kidney (PAK) transplant. With the PAK transplant, there is an initial increase in mortality (which is true for any type of transplant procedure; there is a finite, albeit low, perioperative mortality risk). In a retrospective study of over 11,000 patients with diabetes on the waitlist from 1995 to 2000, mortality within four years of transplantation was evaluated among those who underwent PAK, SPK, and pancreas transplant alone (PTA) versus patients waiting for the same procedure [<a href="#rid3">3</a>]. Overall relative risk (RR) of all-cause mortality at four years was significantly higher for those who underwent PAK transplant versus those on the waitlist for PAK transplant (RR 1.42, 95% CI 1.03-1.94). The higher mortality risk in this study was primarily due to deaths occurring in the first three months posttransplant. However, in a follow-up study using the same database and controlling for confounding variables such as duplicate counts, a multivariate analysis demonstrated similar mortality among patients with diabetes who underwent PAK transplantation compared with those on the waiting list for PAK transplant [<a href="#rid13">13</a>].</p><p>Another study based on the UNOS database between 1997 and 2007 compared living-donor KTA with a functioning allograft at one year (n = 2989) versus pancreas after living-donor kidney transplant that had occurred within the first year post-kidney transplantation (n = 484) [<a href="#rid68">68</a>]. Compared with living-donor KTA and after adjusting for multiple donor- and recipient-related factors, despite the initial increase in mortality, PAK recipients had a nonsignificant trend toward better survival at eight-year follow-up (adjusted HR 0.78, 95% CI 0.57-1.07).</p><p class="headingAnchor" id="H516802952"><span class="h2">Kidney allograft survival</span><span class="headingEndMark"> — </span>Overall, kidney allograft survival rates among type 1 diabetic recipients of SPK transplants are generally comparable with those seen with living-donor KTAs and superior to those observed after deceased-donor KTAs [<a href="#rid69">69</a>]. The reason for the improved kidney allograft survival among SPK recipients compared with recipients of deceased-donor KTAs likely reflects the effects of prolonged euglycemia in recipients with functional pancreas allografts, demographic and clinical differences in the patients with type 1 diabetes who are selected for SPK versus KTA, and deceased-donor organ quality (younger donors and shorter waiting times for SPK recipients). Overall, SPK candidates are younger, have a lower body mass index (BMI), and are more often preemptively transplanted compared with diabetic, deceased-donor KTA recipients. In addition, SPK recipients experience shorter cold ischemia times (CITs), experience less delayed graft function, and more often receive depleting antibody induction agents.</p><p>The beneficial effects of the pancreas allograft on kidney allograft survival in SPK recipients are evident when outcomes are stratified by time from transplantation. One study demonstrated that, after 10 years of transplantation, kidney allografts in SPK recipients were less likely to have allograft failure compared with deceased-donor KTA (adjusted HR 0.58, CI 0.40-0.84) and living-donor KTA (adjusted HR 0.63, CI 0.40-1) [<a href="#rid70">70</a>].</p><p>These benefits were also reported in short-term follow-up based on the function of the pancreas at one year. Kidney allografts in SPK recipients who had a functioning pancreas allograft at one year had significantly better survival compared with kidney allografts in deceased-donor KTAs and living-donor KTAs, whereas recipients with a failed pancreas at one year (13 percent) had a higher probability of kidney failure and higher mortality compared with living-donor but not deceased-donor KTA [<a href="#rid67">67</a>].</p><p>Retrospective data suggest that SPK transplants performed prior to the need for dialysis (eg, preemptive transplantation) may be associated with improved kidney allograft survival compared with SPK transplants performed after the initiation of dialysis [<a href="#rid71">71</a>]. Preemptive SPK transplantation may also be associated with improved long-term patient survival and a greater likelihood of patients returning to gainful employment [<a href="#rid72">72</a>]. In a single-center retrospective study, preemptive SPK transplantation was associated with a kidney (but not pancreas) death-censored survival benefit when adjusting for confounding factors [<a href="#rid73">73</a>]. However, in this study, patients on dialysis undergoing SPK transplantation with a longer duration of pretransplant dialysis did not experience inferior survival outcomes. Similar observations have been made for preemptive transplantation of kidney allografts alone. (See  <a class="medical medical_review" href="/z/d/html/7334.html" rel="external">"Kidney transplantation in adults: Timing of transplantation and issues related to dialysis", section on 'Preemptive transplantation'</a>.)</p><p>Although pancreas transplantation is associated with a finite risk (5 percent) of early graft failure (usually secondary to thrombosis) in all three recipient categories, the mean graft longevity in the absence of early graft loss (conditional graft survival) is 14 years for both the kidney and pancreas grafts following SPK transplantation [<a href="#rid74">74</a>]. Moreover, pancreas graft survival of 25 years and longer was reported in a single-center cohort of SPK transplant recipients [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Other potential benefits</span><span class="headingEndMark"> — </span>In addition to potentially improved survival, pancreas transplantation may decrease morbidity. Studies have examined the effect of pancreas transplantation on multiple sequelae of diabetes including the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Glucose metabolism</p><p class="bulletIndent1"><span class="glyph">●</span>Lipid metabolism and atherosclerosis</p><p class="bulletIndent1"><span class="glyph">●</span>Nephropathy</p><p class="bulletIndent1"><span class="glyph">●</span>Retinopathy</p><p class="bulletIndent1"><span class="glyph">●</span>Circulation</p><p class="bulletIndent1"><span class="glyph">●</span>Fertility</p><p class="bulletIndent1"><span class="glyph">●</span>Fracture risk</p><p></p><p>We discuss the effect of pancreas transplantation on each of these areas below. We focus on studies among kidney transplant recipients. The effects of PTA (ie, in non-end-stage kidney disease [ESKD] patients) are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1767.html" rel="external">"Pancreas and islet transplantation in diabetes mellitus", section on 'Metabolic effects'</a> and  <a class="medical medical_review" href="/z/d/html/1767.html" rel="external">"Pancreas and islet transplantation in diabetes mellitus", section on 'Effects on the chronic complications of diabetes'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Glucose metabolism</strong> – Successful pancreas transplantation is defined as restoration of normoglycemia without the need for exogenous insulin. However, basal and stimulated peripheral serum insulin concentrations are two to three times higher than normal in recipients of pancreas grafts with systemic venous drainage. This hyperinsulinemia is due to the delivery of insulin into the systemic circulation [<a href="#rid76">76,77</a>] so that first-pass hepatic uptake and degradation, which removes 50 to 90 percent of the insulin reaching the liver via the portal vein, are bypassed. Although systemic hyperinsulinemia has been associated with the metabolic syndrome and other complications in the nontransplant setting, there is no evidence to date to suggest that this contrived hyperinsulinemia associated with systemic venous drainage of a pancreas transplant is related to any unique morbidity.</p><p></p><p class="bulletIndent1">Glucose counterregulation also improves after pancreas transplantation because the transplanted pancreas produces not only insulin but also glucagon [<a href="#rid20">20,78,79</a>]. Most recipients have had diabetes for many years and therefore have abnormal counterregulation of hypoglycemia due to decreased glucagon and epinephrine responses (see  <a class="medical medical_review" href="/z/d/html/1808.html" rel="external">"Physiologic response to hypoglycemia in healthy individuals and patients with diabetes mellitus"</a>). Glucagon responses are normalized and epinephrine responses are improved after successful pancreas transplantation. Importantly, symptom recognition of hypoglycemia is restored and occurs at higher blood glucose concentrations [<a href="#rid20">20</a>]. Hypoglycemia may be a complication of pancreas transplantation but has only been reported sporadically [<a href="#rid21">21</a>] and is usually mild.</p><p></p><p class="bulletIndent1">More physiologic control of levels of insulin, glucagon, and glucose, in particular, and carbohydrate metabolism, in general, have been maintained for up to 20 years or longer after successful pancreas transplantation [<a href="#rid80">80-86</a>]. The immediate glucometabolic effects of a functioning pancreas transplant are dramatic and truly render these patients "ex-diabetic." Pancreas transplant recipients have few if any dietary restrictions, and the majority no longer even check their blood glucose levels. A functioning pancreas transplant mitigates glycemic variability, optimizes time in range, eliminates the daily stigma and burden of diabetes, and is the single most effective way of achieving normoglycemia long term for a diabetic patient. Depending on the type of pancreas transplant, the expectation is that 85 to 90 percent of recipients will be rendered completely insulin free at one year posttransplant. The mean pancreas graft life expectancy, which maintains this euglycemic state, is a decade or longer.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lipid metabolism and atherosclerosis</strong> – Serum triglyceride and low-density lipoprotein cholesterol (LDL-C) concentrations tend to fall and serum high-density lipoprotein cholesterol (HDL-C) concentrations tend to rise in recipients of pancreas transplants [<a href="#rid87">87,88</a>]. Several studies have suggested that SPK transplantation may reduce predicted cardiovascular risk as well as the progression of macrovascular disease [<a href="#rid8">8,15,37,41-43,70,89,90</a>]. A longitudinal, single-center retrospective study comparing 101 SPK and 26 KTA recipients with insulin-dependent diabetes mellitus suggested that peripheral vascular complications and progression of peripheral vascular disease were both decreased in SPK recipients, which was attributed to a superior metabolic vascular risk profile [<a href="#rid91">91</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diabetic kidney disease</strong> – Recurrent and de novo diabetic nephropathy is prevented by successful pancreas transplantation [<a href="#rid35">35,92-94</a>]. PTA may reverse established diabetic lesions in patients with early diabetic kidney disease (DKD). In one series, functional and structural analyses of the native kidneys were performed after successful PTA in 13 patients with type 1 diabetes [<a href="#rid93">93</a>]. These patients began with a normal creatinine clearance; nine had moderately increased albuminuria (formerly called "microalbuminuria"), and four had overt proteinuria. When compared at five years with a control group treated with conventional insulin therapy, those with PTA had a lower glomerular filtration rate (GFR) due presumably to the nephrotoxic effect of <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">cyclosporine</a>. However, histologic changes of DKD (increased mesangial and glomerular volume) were stable versus an increase in the control group. Subsequent follow-up of eight of these patients at 10 years suggested that successful pancreas transplantation could eventually reverse established lesions of DKD [<a href="#rid35">35</a>]. Significant reductions were observed in the thickness of the glomerular basement membranes (GBM; 404 versus 594 nm at baseline) and the mesangial fractional volume (0.27 versus 0.33)  (<a class="graphic graphic_figure graphicRef67651" href="/z/d/graphic/67651.html" rel="external">figure 1</a>). All of these patients had pancreas graft survival exceeding 10 years.</p><p></p><p class="bulletIndent1">Ultrastructural benefits of euglycemia have also been shown in kidney allografts. A study of patients with type 1 diabetes mellitus examined kidney allograft structure in living-donor KTA (n = 17) and in SPK recipients (n = 25). Compared with SPK, kidneys of patients who had KTA had wider GBMs (369 versus 281 nm) and increased mesangial fractional volume (0.23 versus 0.16) at a median follow-up of 10 years. This study excluded recipients with either failed kidney or pancreas allografts [<a href="#rid95">95</a>].</p><p></p><p class="bulletIndent1">Data on the effects of pancreas transplantation on native kidney function are limited. One study suggested that PTA might decrease proteinuria. In this study, 32 patients with a functioning PTA had a decrease in protein excretion one year after pancreas transplantation compared with 30 matched patients with type 1 diabetes who did not have a pancreas transplant [<a href="#rid96">96</a>]. However, the use of calcineurin inhibitors independent of the achievement of euglycemia may reduce proteinuria. For patients who undergo PTA, it is estimated that up to 15 percent may eventually develop end-stage kidney disease (ESKD). Nevertheless, the requisite use of calcineurin inhibitors in this population does not appear to accelerate chronic kidney disease (CKD), and it is widely believed that the majority of patients with a functioning pancreas transplant experience a stabilization of nephropathy. In a landmark study of 66 consecutive PTA recipients with 10-year follow-up, only six patients (9 percent) developed stage 4 or 5 chronic kidney disease [<a href="#rid94">94</a>]. In those patients with normoglycemia at 10 years and in the absence of pretransplant macroalbuminuria, 74 percent maintained stable kidney function.</p><p></p><p class="bulletIndent1">As another example of the benefits of sustained euglycemia on nephropathy, in the studies cited above comparing SPK with living- and deceased-donor KTA, patients with a functioning pancreas transplant appear to have the best long-term kidney graft survival rate. In addition, successful PAK transplantation is associated with improved long-term kidney graft function and survival outcomes compared with KTA [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diabetic neuropathy</strong> – There is stabilization and, in some cases, improvement in peripheral and autonomic diabetic neuropathy after pancreas transplantation [<a href="#rid36">36,97-101</a>]. In one study, stabilization of neuropathy was documented by physical examination, sensory nerve conduction, motor nerve conduction, and cardiorespiratory reflex among 115 patients 10 years after transplantation [<a href="#rid36">36</a>].</p><p></p><p class="bulletIndent1">Morphologic changes among transplant recipients may be seen much earlier. Using corneal confocal microscopy (CCM), which is a highly sensitive technique to examine early nerve damage in patients with diabetes, a significant improvement was demonstrated in nerve morphology (nerve fiber density, branch density, and length) among 15 patients with diabetes 12 months after pancreas transplantation compared with baseline [<a href="#rid102">102,103</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diabetic retinopathy</strong> – Diabetic retinopathy is a common microvascular complication of diabetes [<a href="#rid104">104,105</a>]. (See  <a class="medical medical_review" href="/z/d/html/1783.html" rel="external">"Diabetic retinopathy: Classification and clinical features", section on 'Prevalence and natural history'</a>.)</p><p></p><p class="bulletIndent1">Approximately 80 percent of pancreas transplant candidates have diabetic retinopathy at the time of transplant [<a href="#rid106">106</a>]. The effect of pancreas transplant on diabetic retinopathy is not clear. Some studies have found no benefit in terms of halting or reversing the progression of advanced retinopathy after pancreas transplantation [<a href="#rid107">107-109</a>].</p><p></p><p class="bulletIndent1">Other reports, however, have noted stabilization or occasional regression of retinal lesions following successful pancreas transplantation [<a href="#rid110">110,111</a>]. The difference between studies might be related to the use of different methods of classifying diabetic retinopathy. One study found that recipients of SPK transplants had less retinal damage (ascertained by funduscopy and the need for laser treatment) three years after transplant compared with a group receiving KTA [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1">Another study showed that 79 percent of SPK recipients experienced stabilization in diabetic retinopathy, 10 percent progressed, and 10 percent improved at a median follow-up of 17 months, whereas 49 percent of the matched control group of patients with diabetes (with no transplant) progressed  (<a class="graphic graphic_figure graphicRef103315" href="/z/d/graphic/103315.html" rel="external">figure 2</a>) [<a href="#rid112">112</a>]. None with advanced-grade or laser-treated diabetic retinopathy were improved in either group. The concern that early worsening of diabetic retinopathy due to sudden glucose normalization and perioperative morbidity following pancreas transplantation has been largely refuted [<a href="#rid113">113,114</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fracture risk</strong> – The risk of fracture may be lower following SPK transplant compared with that after KTA. This was suggested by a retrospective analysis of 11,145 diabetic transplant recipients (4933 SPK and 6212 KTA recipients) who were identified from the United States Renal Data System (USRDS) [<a href="#rid115">115</a>]. After adjusting for multiple covariates, SPK transplantation was associated with a lower fracture risk (HR 0.79, 95% CI 0.66-0.96). The protective effect of SPK transplant on fracture was particularly evident among men. The reasons underlying the apparent protective effect of SPK transplantation on fractures cannot be determined from this retrospective study [<a href="#rid116">116</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reproductive health</strong> – The International Pancreas Transplant Registry (IPTR) has reported 47 pregnancies among 34 pancreas-kidney recipients, which resulted in 38 live, healthy infants. Excellent metabolic control was observed in all pregnancies. Adverse results included the loss of a pancreas and a kidney allograft in two patients and the acceleration of retinopathy in another. Several other studies have documented the safety of planned pregnancy in SPK recipients with stable kidney and pancreas allograft function [<a href="#rid117">117-120</a>]. (See  <a class="medical medical_review" href="/z/d/html/113826.html" rel="external">"Sexual and reproductive health after kidney transplantation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Quality of life</strong> – SPK transplantation has been shown to improve quality of life compared with KTA [<a href="#rid7">7,22-28,31-34</a>]. Pancreas transplantation offers the benefits of independence from finger sticks for glucose monitoring and from insulin injections, avoidance of hypoglycemic episodes, and reduced risk of developing diabetic retinopathy and neuropathy [<a href="#rid65">65,121</a>]. In one study of patients with type 1 diabetes and ESKD, SPK transplantation was more cost effective over five years than KTA or dialysis after adjusting for quality of life [<a href="#rid122">122,123</a>].</p><p></p><p class="headingAnchor" id="H10"><span class="h1">COMPLICATIONS</span></p><p class="headingAnchor" id="H11"><span class="h2">General complications</span><span class="headingEndMark"> — </span>Complications are generally more severe and common in the first year posttransplant in simultaneous pancreas-kidney (SPK) transplant compared with kidney transplantation alone (KTA) recipients and are generally related either to the more complex surgery or to immunosuppression that is required.</p><p>Due to perioperative complications, greater morbidity and early mortality is associated with SPK compared with KTA. This difference is reflected by longer initial hospital stay, more frequent rehospitalization during the first 30 days (55 percent after SPK versus 30 percent after KTA) and first year posttransplant, greater severity of illness requiring rehospitalization, and increased risk of perioperative mortality [<a href="#rid13">13,124-127</a>]. Surgical complications (including graft thrombosis) can also occur after pancreas after kidney (PAK) and pancreas transplantation alone (PTA), resulting in part in inferior pancreas graft survival rates in solitary pancreas (PAK or PTA) compared with SPK transplants [<a href="#rid45">45,128-131</a>]. Approximately 5 to 8 percent of all pancreas transplants in the United States are lost secondary to early technical failure (depending upon transplant category) with reoperative rates ranging from 12 to 43 percent [<a href="#rid74">74,132-141</a>]. Graft thrombosis (primarily venous in origin) continues to be the leading cause of technical failure, accounting for 80 percent of early technical pancreas graft losses [<a href="#rid132">132-135,137-144</a>]. Other reasons for early technical failure include anastomotic leaks, pancreatitis, bleeding, infection, and primary nonfunction. In addition, metabolic derangements and gastrointestinal, urologic, and wound complications may contribute to poor early outcomes and morbidity. However, early relaparotomy rates have continued to decrease over time with better donor selection, minimization of cold ischemia time, and improved techniques of enteric drainage of the exocrine secretions [<a href="#rid132">132-146</a>].</p><p class="headingAnchor" id="H516802452"><span class="h2">Pancreas failure</span><span class="headingEndMark"> — </span>Until recently, a uniform definition of pancreas graft failure was lacking. Pancreas graft failure has been defined by resumption of diabetes medications, which may include any chronic medication, insulin only, or medications near or exceeding those required pretransplant [<a href="#rid147">147</a>]. Pancreas graft failure has also been defined by absence of measurable C-peptide or by elevated glycated hemoglobin (HbA1c) levels. Considering this important limitation, the one- and five-year unadjusted pancreas graft survival rates in SPK recipients are approximately 89 and 75 percent, respectively [<a href="#rid148">148</a>]. Five-year graft survival rates for PTA and PAK transplants are inferior to SPK transplants, at 57 and 65 percent, respectively. The inferior graft survival rates among solitary pancreas transplant recipients have been attributed to higher rates of early thrombosis and acute rejection in the absence of a simultaneously transplanted kidney. (See  <a class="medical medical_review" href="/z/d/html/102979.html" rel="external">"Pancreas allograft rejection"</a>.)</p><p>In 2018, the United Network for Organ Sharing (UNOS) Pancreas Transplantation Committee implemented a new standardized definition for pancreas graft failure that is to be used for program-specific reporting to the International Pancreas Transplant Registry (IPTR) and the Scientific Registry of Transplant Recipients (SRTR). The new definition of pancreas graft failure includes any of the following criteria:</p><p class="bulletIndent1"><span class="glyph">●</span>A recipient's transplanted pancreas is removed</p><p class="bulletIndent1"><span class="glyph">●</span>A recipient re-registers for a pancreas</p><p class="bulletIndent1"><span class="glyph">●</span>A recipient registers for an islet transplant after receiving a pancreas transplant</p><p class="bulletIndent1"><span class="glyph">●</span>A recipient's insulin use is ≥0.5 units/kg/day for 90 consecutive days</p><p class="bulletIndent1"><span class="glyph">●</span>A recipient dies</p><p></p><p>However, this definition is not perfect, because some patients may have been managed pretransplant with total daily insulin requirements of &lt;0.5 units/kg/day whereas others may have a (partially) functioning graft but develop insulin resistance from either posttransplant weight gain or medication. Attempts to incorporate either C-peptide or glycated hemoglobin levels into the definition have proven to be difficult and unreliable.</p><p>The early (first three months) technical failure rate for pancreas recipients in the United States is approximately 5 percent for SPK, 5.5 percent for PAK, and 7 percent for PTA recipients, with graft thrombosis accounting for the majority of these early graft losses [<a href="#rid74">74</a>]. Graft thrombosis occurs primarily in the first week following transplant and is associated with graft pancreatitis, hypotension, reperfusion injury, and prolonged cold ischemia times (CITs), as well as hypercoagulable states. Other causes of early technical failure (in descending order of frequency) include infection, pancreatitis, anastomotic leak, bleeding, and primary nonfunction in the absence of thrombosis. Early technical failure rates may be greater with higher donor or recipient body mass index (BMI). Early technical failures account for over one-half of graft losses in the first posttransplant year and usually necessitate graft pancreatectomy [<a href="#rid124">124,149,150</a>]. Between 2015 and 2019, however, early technical failure rates have decreased to 5 to 7 percent in all three categories of pancreas transplants (SPK, PAK, and PTA). From 3 to 12 months posttransplant, the primary causes of graft failure include acute or chronic rejection, death with a functioning graft, and infection. One-year rates of immunologic pancreas graft loss are 1.4 percent in SPK and 3 to 5 percent in solitary pancreas transplant recipients.</p><p class="headingAnchor" id="H544458249"><span class="h3">Donor factors</span><span class="headingEndMark"> — </span>Donor factors influence surgical complications, technical failures, and long-term pancreas allograft survival [<a href="#rid151">151-153</a>].</p><p>In a single-center study, technical failure (defined as graft loss within the first 90 days following transplantation) was 10.2 percent. Thrombosis and pancreatitis were the leading etiologies. Donor risk factors for technical failure were age &gt;50 years, BMI ≥30 kg/m<sup>2</sup>, serum creatinine ≥2.5 mg/dL, and preservation time &gt;20 hours [<a href="#rid150">150</a>].</p><p>In a separate analysis using data from the SRTR, donor risk factors for pancreas allograft failure including sex, age, race, BMI, height, cause of death, preservation time, donation after cardiac death (DCD), and creatinine were used to create a pancreas donor risk index (PDRI) to estimate the risk of early pancreas failure. Increased PDRI was significantly associated with graft loss within the first posttransplant year for all types of pancreas transplants. Donors with PDRI less than 1.16 (SPK) or less than 0.86 (PTA) had the best survival probability at one year [<a href="#rid154">154</a>].</p><p>Mild donor obesity was examined in a different study that found that pancreata from donors with BMI 30 to 35 kg/m<sup>2</sup> did not carry a higher risk of pancreas graft failure at short- and long-term follow-up compared with pancreata from lean donors (BMI 20 to 25 kg/m<sup>2</sup>) [<a href="#rid155">155</a>].</p><p>Although these models in theory can be used to improve the utilization of donors perceived to be at higher risk, in practice they are not used prospectively in donor evaluation or clinical decision-making pursuant to a given pancreas offer.</p><p class="headingAnchor" id="H544461796"><span class="h3">Recipient factors</span><span class="headingEndMark"> — </span>Recipients over age 45 years carry a twofold greater risk of graft loss, most often due to technical failure, and a threefold greater risk of dying than younger patients [<a href="#rid151">151,156,157</a>]. However, some highly selected older individuals may do as well as younger individuals. The selection of individuals for SPK transplantation is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7305.html" rel="external">"Pancreas-kidney transplantation in diabetes mellitus: Patient selection and pretransplant evaluation", section on 'Patient selection'</a>.)</p><p>In the IPTR data report, for example, there was little difference in pancreas allograft survival rates between SPK recipients 30 to 40 years of age and those older than 40 years of age [<a href="#rid158">158</a>].</p><p>An analysis of the UNOS database including 20,854 pancreas transplant recipients between 1996 and 2012 demonstrated that graft survival was superior in recipients 40 to 49 years of age, with reduced patient survival in those 50 to 59 years of age and poor graft and patient survival in those &gt;60 years of age [<a href="#rid159">159</a>].</p><p>Age cut-off for pancreas transplant varies by center within the United States between 45 and 65 years old. We believe that highly selected patients between the ages 50 to 60 years may benefit from SPK transplantation if they do not have significant comorbidities such as advanced cardiovascular, cerebrovascular, or peripheral vascular disease [<a href="#rid160">160-162</a>].</p><p>In addition, inferior pancreas outcomes are more common among patients with obesity (defined as BMI &gt;30 kg/m<sup>2</sup>) [<a href="#rid163">163,164</a>] and among Black patients [<a href="#rid165">165-169</a>].</p><p class="headingAnchor" id="H15067157"><span class="h2">Infection</span><span class="headingEndMark"> — </span>The immunosuppressive strategies used in SPK and PAK transplantation expose the patient to an increased risk of bacterial, fungal, and viral infections. As with other immunosuppressed transplant recipients, cytomegalovirus (CMV) infection is among the most common viruses causing clinically significant infection in SPK recipients. In the EuroSPK 001 study, for example, the rate of CMV infection following SPK transplantation, was 11, 40, 37, and 52 percent, for donor-minus (D-)/recipient-minus (R-), D-/R+, D+/R+, and D+/R- pairs, respectively [<a href="#rid170">170-173</a>]. Up to 63 percent of patients with diabetes who undergo pancreas transplantation are CMV seronegative. This circumstance may further increase the risk of CMV infection, particularly in the setting of depleting antibody induction (which is administered in 85 percent of pancreas transplant recipients).</p><p class="bulletIndent1">As in kidney transplant recipients, BK virus may be a significant cause of kidney graft loss in SPK recipients [<a href="#rid174">174</a>]. The major diseases caused by BK virus are tubulointerstitial nephritis and ureteral stenosis. (See  <a class="medical medical_review" href="/z/d/html/7338.html" rel="external">"Kidney transplantation in adults: BK polyomavirus-associated nephropathy"</a>.)</p><p></p><p class="headingAnchor" id="H13"><span class="h2">Metabolic disturbances</span><span class="headingEndMark"> — </span>The traditional method of exocrine pancreas drainage was to the bladder because it revolutionized the safety of the transplant procedure in the late 1980s to early 1990s. However, metabolic disorders (acidosis, dehydration) associated with bladder drainage prompted a shift to pancreas transplantation using enteric drainage in the late 1990s and thereafter. SPK with bladder drainage is associated with numerous metabolic and hemodynamic disturbances including normal anion gap metabolic acidosis, hyponatremia, dehydration, and orthostasis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metabolic acidosis –</strong> SPK transplantation with bladder exocrine drainage is often associated with the loss of large quantities of bicarbonate-rich pancreatic secretions into the urine, leading to a normal anion gap metabolic acidosis, hyponatremia, and volume depletion. The hyponatremia is presumably due to the combination of hypovolemia-induced stimulation of the release of antidiuretic hormone and the replacement of solute-rich pancreatic secretions with free water. As a result, many SPK recipients with bladder drainage require chronic <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> supplementation; the dose is often as high as 100 to 150 mEq/day.</p><p></p><p class="bulletIndent1">Problems with acidosis and volume depletion are greatly reduced with enteric exocrine drainage of the pancreas graft [<a href="#rid125">125,126,145</a>]. In a single-center report of 30 and 23 patients with bladder and enteric drainage, respectively, the incidence of metabolic acidosis was significantly lower in those with enteric drainage (0 versus 83 percent) [<a href="#rid126">126</a>]. In the new millennium, approximately 90 percent of pancreas transplants are performed with enteric drainage in all three categories. Surgical considerations including pancreatic drainage are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/118566.html" rel="external">"Pancreas-kidney transplantation in diabetes mellitus: Surgical considerations and immunosuppression", section on 'Surgical considerations'</a> and  <a class="medical medical_review" href="/z/d/html/118566.html" rel="external">"Pancreas-kidney transplantation in diabetes mellitus: Surgical considerations and immunosuppression", section on 'Bladder versus enteric exocrine drainage'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyperglycemia –</strong> Hyperglycemia can result from pancreatic dysfunction due to rejection or technical problems, to calcineurin inhibitor toxicity, or to recurrent diabetes. <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">Cyclosporine</a> and <a class="drug drug_general" data-topicid="9971" href="/z/d/drug information/9971.html" rel="external">tacrolimus</a> both adversely affect beta cell function [<a href="#rid175">175,176</a>]. These effects include decreased insulin gene expression, decreased stability of insulin messenger RNA (mRNA), decreased insulin synthesis, and decreased insulin secretion in vivo [<a href="#rid177">177</a>]. In addition, glucocorticoids can cause insulin resistance and weight gain, which in some cases can lead to the development of type 2 diabetes posttransplant. (See  <a class="medical medical_review" href="/z/d/html/7327.html" rel="external">"Kidney transplantation in adults: Posttransplantation diabetes mellitus"</a>.)</p><p></p><p class="bulletIndent1">Recurrent autoimmunity may also cause hyperglycemia [<a href="#rid127">127,178-180</a>].</p><p></p><p class="headingAnchor" id="H23063304"><span class="h2">Posttransplant erythrocytosis (PTE)</span><span class="headingEndMark"> — </span>PTE is defined as persistently elevated hemoglobin and hematocrit levels that occur following kidney transplantation and persist for more than six months in the absence of thrombocytosis, leukocytosis, or another potential cause of erythrocytosis. One single-center, retrospective analysis has suggested that PTE may be more common among recipients of SPK compared with KTA [<a href="#rid181">181</a>] (see  <a class="medical medical_review" href="/z/d/html/7348.html" rel="external">"Kidney transplantation in adults: Posttransplant erythrocytosis", section on 'Risk factors'</a>). However, with the advent of enteric exocrine drainage, the incidence of PTE has decreased dramatically and is no longer a common problem, potentially owing to less dehydration than with bladder drainage and contemporaneous changes in immunosuppressant agents.</p><p class="headingAnchor" id="H544457946"><span class="h2">Other complications</span><span class="headingEndMark"> — </span>Other common nonimmunologic complications include wound problems, gross hematuria, recurrent urinary tract infections (UTIs), and vascular thrombosis [<a href="#rid13">13,124-126,132-146</a>].</p><p>In a retrospective review that compared 276 SPK with 1833 KTA recipients, following SPK transplant, there was an increase in the risk of deep venous thrombosis (DVT; 18 versus 6 percent) and pulmonary thromboembolism (4.7 versus 1.7 percent) [<a href="#rid182">182</a>]. DVT tended to occur more often on the side of the pancreas than the kidney (57 versus 43 percent), and the risk of DVT was greatest in the first posttransplant month.</p><p>Patients with bladder-drained pancreata are more likely to have hematuria, urethritis, urethral stricture, UTIs, and urine leak than enteric-drained pancreata [<a href="#rid125">125,126</a>]. Exocrine drainage into the bladder is not physiologic and results in a unique set of urologic, metabolic, infectious, and other issues that can be difficult to manage and can become chronically debilitating for patients. In this setting, patients with intractable, recurrent, or refractory complications were then treated with open conversion from bladder to enteric drainage (enteric conversion). Enteric conversion is in essence a surgical complication of bladder drainage [<a href="#rid145">145,183-185</a>]. Paradoxically, the success of enteric conversion paved the way for the resurgence of interest in primary enteric drainage. Rates of enteric conversion range from 10 to 40 percent in some series, but several studies have reported excellent long-term pancreas (and kidney) graft function with significant resolution of symptoms, even if the enteric conversion is performed several years following SPK transplantation.</p><p class="headingAnchor" id="H2737584853"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110754.html" rel="external">"Society guideline links: Kidney transplantation"</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General principles </strong>– Simultaneous pancreas-kidney (SPK) transplantation is an established treatment for selected patients with insulin-requiring diabetes with either advanced chronic kidney disease (CKD) or end-stage kidney disease (ESKD). In the United States, nearly 90 percent of pancreas transplants are performed as SPK transplants, with the remainder performed as sequential pancreas after kidney (PAK) transplant or pancreas transplant alone (PTA). While SPK usually employs grafts procured from a single deceased donor, PAK typically involves transplantation of a cadaveric pancreas graft into a recipient with either a functioning living- or deceased-donor kidney allograft. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Benefits </strong>– The major benefits of SPK transplantation are decreased mortality and improved quality of life. The decreased mortality is due in part to the well-established survival benefit conferred by kidney transplantation (ie, even without pancreas transplantation) compared with dialysis. Our understanding of the relative benefits of SPK compared with kidney transplantation alone (KTA) is hampered by the absence of any randomized trials. All of the claims regarding the benefits of pancreas transplantation are based on limited and generally poorly controlled studies. Potential benefits of SPK transplantation include improved glucose and lipid metabolism, possibly a decrease in the risk of recurrent diabetic kidney disease, and stabilization and improvement in neuropathy and retinopathy. (See <a class="local">'Benefits'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications </strong>– Nonimmunologic complications are the most severe in the first three months posttransplant and generally relate to the surgery or the immunosuppression required. Technical failures occur in approximately 5 to 8 percent of recipients depending on type of transplant, with graft thrombosis as the leading cause. Other complications may include graft pancreatitis, infections (intra-abdominal, urinary), wound issues, and systemic viral infections. (See <a class="local">'General complications'</a> above.)</p><p></p><p class="headingAnchor" id="H1029635470"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges R Paul Robertson, MD, and Christina L Klein, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kandaswamy R, Stock PG, Miller J, et al. OPTN/SRTR 2020 Annual Data Report: Pancreas. Am J Transplant 2022; 22 Suppl 2:137.</a></li><li><a class="nounderline abstract_t">Redfield RR, Scalea JR, Odorico JS. Simultaneous pancreas and kidney transplantation: current trends and future directions. Curr Opin Organ Transplant 2015; 20:94.</a></li><li><a class="nounderline abstract_t">Venstrom JM, McBride MA, Rother KI, et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290:2817.</a></li><li><a class="nounderline abstract_t">Esmeijer K, Hoogeveen EK, van den Boog PJM, et al. Superior Long-term Survival for Simultaneous Pancreas-Kidney Transplantation as Renal Replacement Therapy: 30-Year Follow-up of a Nationwide Cohort. Diabetes Care 2020; 43:321.</a></li><li><a class="nounderline abstract_t">Sung RS, Zhang M, Schaubel DE, et al. A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation. Transplantation 2015; 99:1900.</a></li><li><a class="nounderline abstract_t">Rana A, Gruessner A, Agopian VG, et al. Survival benefit of solid-organ transplant in the United States. JAMA Surg 2015; 150:252.</a></li><li><a class="nounderline abstract_t">Shingde R, Calisa V, Craig JC, et al. Relative survival and quality of life benefits of pancreas-kidney transplantation, deceased kidney transplantation and dialysis in type 1 diabetes mellitus-a probabilistic simulation model. Transpl Int 2020; 33:1393.</a></li><li><a class="nounderline abstract_t">van Dellen D, Worthington J, Mitu-Pretorian OM, et al. Mortality in diabetes: pancreas transplantation is associated with significant survival benefit. Nephrol Dial Transplant 2013; 28:1315.</a></li><li><a class="nounderline abstract_t">Salvalaggio PR, Dzebisashvili N, Pinsky B, et al. Incremental value of the pancreas allograft to the survival of simultaneous pancreas-kidney transplant recipients. Diabetes Care 2009; 32:600.</a></li><li><a class="nounderline abstract_t">Parajuli S, Arunachalam A, Swanson KJ, et al. Outcomes after simultaneous kidney-pancreas versus pancreas after kidney transplantation in the current era. Clin Transplant 2019; 33:e13732.</a></li><li><a class="nounderline abstract_t">Barlow AD, Saeb-Parsy K, Watson CJE. An analysis of the survival outcomes of simultaneous pancreas and kidney transplantation compared to live donor kidney transplantation in patients with type 1 diabetes: a UK Transplant Registry study. Transpl Int 2017; 30:884.</a></li><li><a class="nounderline abstract_t">Fridell JA, Niederhaus S, Curry M, et al. The survival advantage of pancreas after kidney transplant. Am J Transplant 2019; 19:823.</a></li><li><a class="nounderline abstract_t">Gruessner RW, Sutherland DE, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant 2004; 4:2018.</a></li><li><a class="nounderline abstract_t">Kukla A, Ventura-Aguiar P, Cooper M, et al. Transplant Options for Patients With Diabetes and Advanced Kidney Disease: A Review. Am J Kidney Dis 2021; 78:418.</a></li><li><a class="nounderline abstract_t">Lindahl JP, Hartmann A, Aakhus S, et al. Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation. Diabetologia 2016; 59:844.</a></li><li><a class="nounderline abstract_t">Das DM, Huskey JL, Harbell JW, et al. Early technical pancreas failure in Simultaneous Pancreas-Kidney Recipients does not impact renal allograft outcomes. Clin Transplant 2021; 35:e14138.</a></li><li><a class="nounderline abstract_t">Lehner LJ, Öllinger R, Globke B, et al. Impact of Early Pancreatic Graft Loss on Outcome after Simultaneous Pancreas-Kidney Transplantation (SPKT)-A Landmark Analysis. J Clin Med 2021; 10.</a></li><li><a class="nounderline abstract_t">Nathan DM, Fogel H, Norman D, et al. Long-term metabolic and quality of life results with pancreatic/renal transplantation in insulin-dependent diabetes mellitus. Transplantation 1991; 52:85.</a></li><li><a class="nounderline abstract_t">Becker BN, Odorico JS, Becker YT, et al. Simultaneous pancreas-kidney and pancreas transplantation. J Am Soc Nephrol 2001; 12:2517.</a></li><li><a class="nounderline abstract_t">Kendall DM, Rooney DP, Smets YF, et al. Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 1997; 46:249.</a></li><li><a class="nounderline abstract_t">Cottrell DA, Henry ML, O'Dorisio TM, et al. Hypoglycemia after successful pancreas transplantation in type I diabetic patients. Diabetes Care 1991; 14:1111.</a></li><li><a class="nounderline abstract_t">Isla Pera P, Moncho Vasallo J, Torras Rabasa A, et al. Quality of life in simultaneous pancreas-kidney transplant recipients. Clin Transplant 2009; 23:600.</a></li><li><a class="nounderline abstract_t">Smith GC, Trauer T, Kerr PG, Chadban SJ. Prospective quality-of-life monitoring of simultaneous pancreas and kidney transplant recipients using the 36-item short form health survey. Am J Kidney Dis 2010; 55:698.</a></li><li><a class="nounderline abstract_t">Martins LS, Outerelo C, Malheiro J, et al. Health-related quality of life may improve after transplantation in pancreas-kidney recipients. Clin Transplant 2015; 29:242.</a></li><li><a class="nounderline abstract_t">Hanlon M, Cooper M, Abrams P. Quality of life after pancreas transplantation: time to look again. Curr Opin Organ Transplant 2019; 24:451.</a></li><li><a class="nounderline abstract_t">Posegger KR, Linhares MM, Mucci S, et al. The quality of life in type I diabetic patients with end-stage kidney disease before and after simultaneous pancreas-kidney transplantation: a single-center prospective study. Transpl Int 2020; 33:330.</a></li><li><a class="nounderline abstract_t">Gibbons A, Cinnirella M, Bayfield J, et al. Changes in quality of life, health status and other patient-reported outcomes following simultaneous pancreas and kidney transplantation (SPKT): a quantitative and qualitative analysis within a UK-wide programme. Transpl Int 2020; 33:1230.</a></li><li><a class="nounderline abstract_t">Nijhoff MF, Hovens JGFM, Huisman SD, et al. Psychological Symptoms and Quality of Life After Simultaneous Kidney and Pancreas Transplantation. Transplant Direct 2020; 6:e552.</a></li><li><a class="nounderline abstract_t">Rajkumar T, Mazid S, Vucak-Dzumhur M, et al. Health-related quality of life following kidney and simultaneous pancreas kidney transplantation. Nephrology (Carlton) 2019; 24:975.</a></li><li><a class="nounderline abstract_t">Scheuermann U, Rademacher S, Jahn N, et al. Impact of pre-transplant dialysis modality on the outcome and health-related quality of life of patients after simultaneous pancreas-kidney transplantation. Health Qual Life Outcomes 2020; 18:303.</a></li><li><a class="nounderline abstract_t">Gross CR, Limwattananon C, Matthees BJ. Quality of life after pancreas transplantation: a review. Clin Transplant 1998; 12:351.</a></li><li><a class="nounderline abstract_t">Joseph JT, Baines LS, Morris MC, Jindal RM. Quality of life after kidney and pancreas transplantation: a review. Am J Kidney Dis 2003; 42:431.</a></li><li class="breakAll">Stratta RJ. Pancreas transplantation: Long-term aspects and effect on quality of life. In: Pancreas and islet transplantation, 1, Hakim NS, Stratta RJ, Gray D (Eds), Oxford University Press, New York 2002. p.229.</li><li class="breakAll">Stratta RJ, Zuckerman JM. Quality issues in prancreas transplantation. In: Pancreas, islet and stem cell transplantation for diabetes, 2, Hakim NS, Stratta RJ, Gray D, Friend P, Colman A (Eds), Oxford University Press, New York 2010. p.263.</li><li><a class="nounderline abstract_t">Fioretto P, Steffes MW, Sutherland DE, et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339:69.</a></li><li><a class="nounderline abstract_t">Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997; 42:727.</a></li><li><a class="nounderline abstract_t">Jukema JW, Smets YF, van der Pijl JW, et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 2002; 25:906.</a></li><li><a class="nounderline abstract_t">Koznarová R, Saudek F, Sosna T, et al. Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant 2000; 9:903.</a></li><li><a class="nounderline abstract_t">Dunn TB. Life after pancreas transplantation: reversal of diabetic lesions. Curr Opin Organ Transplant 2014; 19:73.</a></li><li><a class="nounderline abstract_t">Lentine KL, Alhamad T, Cheungpasitporn W, et al. Impact of Functional Status on Outcomes of Simultaneous Pancreas-kidney Transplantation: Risks and Opportunities for Patient Benefit. Transplant Direct 2020; 6:e599.</a></li><li><a class="nounderline abstract_t">Jenssen T, Hartmann A, Birkeland KI. Long-term diabetes complications after pancreas transplantation. Curr Opin Organ Transplant 2017; 22:382.</a></li><li><a class="nounderline abstract_t">Boggi U, Rosati CM, Marchetti P. Follow-up of secondary diabetic complications after pancreas transplantation. Curr Opin Organ Transplant 2013; 18:102.</a></li><li><a class="nounderline abstract_t">Boggi U, Vistoli F, Andres A, et al. First World Consensus Conference on pancreas transplantation: Part II - recommendations. Am J Transplant 2021; 21 Suppl 3:17.</a></li><li><a class="nounderline abstract_t">Sampaio MS, Kuo HT, Bunnapradist S. Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients. Clin J Am Soc Nephrol 2011; 6:1198.</a></li><li><a class="nounderline abstract_t">Gruessner AC, Gruessner RWG. Pancreas Transplantation for Patients with Type 1 and Type 2 Diabetes Mellitus in the United States: A Registry Report. Gastroenterol Clin North Am 2018; 47:417.</a></li><li><a class="nounderline abstract_t">Al-Qaoud TM, Odorico JS, Redfield RR 3rd. Pancreas transplantation in type 2 diabetes: expanding the criteria. Curr Opin Organ Transplant 2018; 23:454.</a></li><li><a class="nounderline abstract_t">Stratta RJ, Rogers J, Farney AC, et al. Pancreas transplantation in C-peptide positive patients: does "type" of diabetes really matter? J Am Coll Surg 2015; 220:716.</a></li><li><a class="nounderline abstract_t">Andacoglu OM, Himmler A, Geng X, et al. Comparison of glycemic control after pancreas transplantation for Type 1 and Type 2 diabetic recipients at a high volume center. Clin Transplant 2019; 33:e13656.</a></li><li><a class="nounderline abstract_t">Gruessner AC, Laftavi MR, Pankewycz O, Gruessner RWG. Simultaneous Pancreas and Kidney Transplantation-Is It a Treatment Option for Patients With Type 2 Diabetes Mellitus? An Analysis of the International Pancreas Transplant Registry. Curr Diab Rep 2017; 17:44.</a></li><li><a class="nounderline abstract_t">Cao Y, Liu X, Lan X, et al. Simultaneous pancreas and kidney transplantation for end-stage kidney disease patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Langenbecks Arch Surg 2022; 407:909.</a></li><li><a class="nounderline abstract_t">Pham PH, Stalter LN, Martinez EJ, et al. Single center results of simultaneous pancreas-kidney transplantation in patients with type 2 diabetes. Am J Transplant 2021; 21:2810.</a></li><li><a class="nounderline abstract_t">Amara D, Hansen KS, Kupiec-Weglinski SA, et al. Pancreas Transplantation for Type 2 Diabetes: A Systematic Review, Critical Gaps in the Literature, and a Path Forward. Transplantation 2022; 106:1916.</a></li><li><a class="nounderline abstract_t">Alhamad T, Kunjal R, Wellen J, et al. Three-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation in type 2 diabetes patients. Am J Transplant 2020; 20:788.</a></li><li><a class="nounderline abstract_t">Witczak BJ, Jenssen T, Endresen K, et al. Risk factors for mortality in diabetic nephropathy patients accepted for transplantation. Transplantation 2007; 84:356.</a></li><li><a class="nounderline abstract_t">La Rocca E, Fiorina P, di Carlo V, et al. Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 2001; 60:1964.</a></li><li><a class="nounderline abstract_t">Cohen DJ, St Martin L, Christensen LL, et al. Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant 2006; 6:1153.</a></li><li><a class="nounderline abstract_t">Mai ML, Ahsan N, Gonwa T. The long-term management of pancreas transplantation. Transplantation 2006; 82:991.</a></li><li><a class="nounderline abstract_t">Smets YF, Westendorp RG, van der Pijl JW, et al. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999; 353:1915.</a></li><li><a class="nounderline abstract_t">Becker BN, Brazy PC, Becker YT, et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 2000; 57:2129.</a></li><li><a class="nounderline abstract_t">Reddy KS, Stablein D, Taranto S, et al. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 2003; 41:464.</a></li><li><a class="nounderline abstract_t">Drognitz O, Benz S, Pfeffer F, et al. Long-term follow-up of 78 simultaneous pancreas-kidney transplants at a single-center institution in Europe. Transplantation 2004; 78:1802.</a></li><li><a class="nounderline abstract_t">Tydén G, Bolinder J, Solders G, et al. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 1999; 67:645.</a></li><li><a class="nounderline abstract_t">Rayhill SC, D'Alessandro AM, Odorico JS, et al. Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg 2000; 231:417.</a></li><li><a class="nounderline abstract_t">Bunnapradist S, Cho YW, Cecka JM, et al. Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. J Am Soc Nephrol 2003; 14:208.</a></li><li><a class="nounderline abstract_t">Sollinger HW, Odorico JS, Becker YT, et al. One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg 2009; 250:618.</a></li><li><a class="nounderline abstract_t">Young BY, Gill J, Huang E, et al. Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database. Clin J Am Soc Nephrol 2009; 4:845.</a></li><li><a class="nounderline abstract_t">Weiss AS, Smits G, Wiseman AC. Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation. Clin J Am Soc Nephrol 2009; 4:988.</a></li><li><a class="nounderline abstract_t">Sampaio MS, Poommipanit N, Cho YW, et al. Transplantation with pancreas after living donor kidney vs. living donor kidney alone in type 1 diabetes mellitus recipients. Clin Transplant 2010; 24:812.</a></li><li><a class="nounderline abstract_t">Gaston RS, Basadonna G, Cosio FG, et al. Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. Am J Kidney Dis 2004; 44:529.</a></li><li><a class="nounderline abstract_t">Morath C, Zeier M, Döhler B, et al. Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft. Clin J Am Soc Nephrol 2010; 5:549.</a></li><li><a class="nounderline abstract_t">Israni AK, Feldman HI, Propert KJ, et al. Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival. Am J Transplant 2005; 5:374.</a></li><li><a class="nounderline abstract_t">Pruijm MT, de Fijter HJ, Doxiadis II, Vandenbroucke JP. Preemptive versus Non-preemptive simultaneous pancreas-kidney transplantation: a single-center, long-term, follow-up study. Transplantation 2006; 81:1119.</a></li><li><a class="nounderline abstract_t">Parajuli S, Swanson KJ, Patel R, et al. Outcomes of simultaneous pancreas and kidney transplants based on preemptive transplant compared to those who were on dialysis before transplant - a retrospective study. Transpl Int 2020; 33:1106.</a></li><li class="breakAll">Angelika Gruessner, Updated International Pancreas Transplant Registry (IPTR) data, 2020, personal communication.</li><li><a class="nounderline abstract_t">Parajuli S, Bath NM, Aziz F, et al. More Than 25 Years of Pancreas Graft Survival After Simultaneous Pancreas and Kidney Transplantation: Experience From the World's Largest Series of Long-term Survivors. Transplantation 2020; 104:1287.</a></li><li><a class="nounderline abstract_t">Diem P, Abid M, Redmon JB, et al. Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 1990; 39:534.</a></li><li><a class="nounderline abstract_t">Luzi L, Secchi A, Facchini F, et al. Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia 1990; 33:549.</a></li><li><a class="nounderline abstract_t">Diem P, Redmon JB, Abid M, et al. Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest 1990; 86:2008.</a></li><li><a class="nounderline abstract_t">Barrou Z, Seaquist ER, Robertson RP. Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia. Diabetes 1994; 43:661.</a></li><li><a class="nounderline abstract_t">Robertson RP. Seminars in medicine of the Beth Israel Hospital, Boston: Pancreatic and islet transplantation for diabetes--cures or curiosities? N Engl J Med 1992; 327:1861.</a></li><li><a class="nounderline abstract_t">Robertson RP, Sutherland DE, Kendall DM, et al. Metabolic characterization of long-term successful pancreas transplants in type I diabetes. J Investig Med 1996; 44:549.</a></li><li><a class="nounderline abstract_t">Robertson RP. Consequences on beta-cell function and reserve after long-term pancreas transplantation. Diabetes 2004; 53:633.</a></li><li><a class="nounderline abstract_t">Hau HM, Jahn N, Brunotte M, et al. Short and long-term metabolic outcomes in patients with type 1 and type 2 diabetes receiving a simultaneous pancreas kidney allograft. BMC Endocr Disord 2020; 20:30.</a></li><li><a class="nounderline abstract_t">Shin S, Jung CH, Choi JY, et al. Long-term Metabolic Outcomes of Functioning Pancreas Transplants in Type 2 Diabetic Recipients. Transplantation 2017; 101:1254.</a></li><li><a class="nounderline abstract_t">Dadlani V, Kaur RJ, Stegall M, et al. Continuous glucose monitoring to assess glycemic control in the first 6 weeks after pancreas transplantation. Clin Transplant 2019; 33:e13719.</a></li><li><a class="nounderline abstract_t">Battezzati A, Benedini S, Caldara R, et al. Prediction of the long-term metabolic success of the pancreatic graft function. Transplantation 2001; 71:1560.</a></li><li><a class="nounderline abstract_t">Larsen JL, Stratta RJ, Ozaki CF, et al. Lipid status after pancreas-kidney transplantation. Diabetes Care 1992; 15:35.</a></li><li><a class="nounderline abstract_t">Katz HH, Nguyen TT, Velosa JA, et al. Effects of systemic delivery of insulin on plasma lipids and lipoprotein concentrations in pancreas transplant recipients. Mayo Clin Proc 1994; 69:231.</a></li><li><a class="nounderline abstract_t">Montagud-Marrahi E, Molina-Andújar A, Pané A, et al. Impact of Simultaneous Pancreas-kidney Transplantation on Cardiovascular Risk in Patients With Diabetes. Transplantation 2022; 106:158.</a></li><li><a class="nounderline abstract_t">Biesenbach G, Königsrainer A, Gross C, Margreiter R. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone. Transpl Int 2005; 18:1054.</a></li><li><a class="nounderline abstract_t">Sucher R, Rademacher S, Jahn N, et al. Effects of simultaneous pancreas-kidney transplantation and kidney transplantation alone on the outcome of peripheral vascular diseases. BMC Nephrol 2019; 20:453.</a></li><li><a class="nounderline abstract_t">Bilous RW, Mauer SM, Sutherland DE, et al. The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med 1989; 321:80.</a></li><li><a class="nounderline abstract_t">Fioretto P, Mauer SM, Bilous RW, et al. Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet 1993; 342:1193.</a></li><li><a class="nounderline abstract_t">Boggi U, Baronti W, Amorese G, et al. Treating Type 1 Diabetes by Pancreas Transplant Alone: A Cohort Study on Actual Long-term (10 Years) Efficacy and Safety. Transplantation 2022; 106:147.</a></li><li><a class="nounderline abstract_t">Lindahl JP, Reinholt FP, Eide IA, et al. In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone. Diabetologia 2014; 57:2357.</a></li><li><a class="nounderline abstract_t">Coppelli A, Giannarelli R, Vistoli F, et al. The beneficial effects of pancreas transplant alone on diabetic nephropathy. Diabetes Care 2005; 28:1366.</a></li><li><a class="nounderline abstract_t">Kennedy WR, Navarro X, Goetz FC, et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990; 322:1031.</a></li><li><a class="nounderline abstract_t">Navarro X, Kennedy WR, Loewenson RB, Sutherland DE. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990; 39:802.</a></li><li><a class="nounderline abstract_t">Allen RD, Al-Harbi IS, Morris JG, et al. Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 1997; 63:830.</a></li><li><a class="nounderline abstract_t">Aridge D, Reese J, Niehoff M, et al. Effect of successful renal and segmental pancreatic transplantation on peripheral and autonomic neuropathy. Transplant Proc 1991; 23:1670.</a></li><li><a class="nounderline abstract_t">Gaber AO, Cardoso S, Pearson S, et al. Improvement in autonomic function following combined pancreas-kidney transplantation. Transplant Proc 1991; 23:1660.</a></li><li><a class="nounderline abstract_t">Hossain P, Sachdev A, Malik RA. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet 2005; 366:1340.</a></li><li><a class="nounderline abstract_t">Tavakoli M, Quattrini C, Abbott C, et al. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 2010; 33:1792.</a></li><li><a class="nounderline abstract_t">Porta M, Bandello F. Diabetic retinopathyA clinical update. Diabetologia 2002; 45:1617.</a></li><li><a class="nounderline abstract_t">Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 2003; 26:2653.</a></li><li><a class="nounderline abstract_t">Scheider A, Meyer-Schwickerath E, Nusser J, et al. Diabetic retinopathy and pancreas transplantation: a 3-year follow-up. Diabetologia 1991; 34 Suppl 1:S95.</a></li><li><a class="nounderline abstract_t">Ramsay RC, Goetz FC, Sutherland DE, et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 1988; 318:208.</a></li><li><a class="nounderline abstract_t">Wang Q, Klein R, Moss SE, et al. The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy. A case series. Ophthalmology 1994; 101:1071.</a></li><li><a class="nounderline abstract_t">Petersen MR, Vine AK. Progression of diabetic retinopathy after pancreas transplantation. The University of Michigan Pancreas Transplant Evaluation Committee. Ophthalmology 1990; 97:496.</a></li><li><a class="nounderline abstract_t">Königsrainer A, Miller K, Steurer W, et al. Does pancreas transplantation influence the course of diabetic retinopathy? Diabetologia 1991; 34 Suppl 1:S86.</a></li><li><a class="nounderline abstract_t">Pearce IA, Ilango B, Sells RA, Wong D. Stabilisation of diabetic retinopathy following simultaneous pancreas and kidney transplant. Br J Ophthalmol 2000; 84:736.</a></li><li><a class="nounderline abstract_t">Giannarelli R, Coppelli A, Sartini M, et al. Effects of pancreas-kidney transplantation on diabetic retinopathy. Transpl Int 2005; 18:619.</a></li><li><a class="nounderline abstract_t">Kim YJ, Shin S, Han DJ, et al. Long-term Effects of Pancreas Transplantation on Diabetic Retinopathy and Incidence and Predictive Risk Factors for Early Worsening. Transplantation 2018; 102:e30.</a></li><li><a class="nounderline abstract_t">Voglová B, Hladíková Z, Nemétová L, et al. Early worsening of diabetic retinopathy after simultaneous pancreas and kidney transplantation-Myth or reality? Am J Transplant 2020; 20:2832.</a></li><li><a class="nounderline abstract_t">Nikkel LE, Iyer SP, Mohan S, et al. Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes. Kidney Int 2013; 83:471.</a></li><li><a class="nounderline abstract_t">Scialla JJ. Choices in kidney transplantation in type 1 diabetes: are there skeletal benefits of the endocrine pancreas? Kidney Int 2013; 83:356.</a></li><li><a class="nounderline abstract_t">Punjala SR, Phillips BL, Chowdhury P, et al. Outcomes of pregnancy in simultaneous pancreas and kidney transplant recipients: A single-center retrospective study. Clin Transplant 2021; 35:e14435.</a></li><li><a class="nounderline abstract_t">Stanic Z, Vulic M, Hrgovic Z, et al. Pregnancy After Simultaneous Pancreas-Kidney Transplantation in Treatment of End-Stage Diabetes Mellitus: a Review. Z Geburtshilfe Neonatol 2022; 226:86.</a></li><li><a class="nounderline abstract_t">Caretto A, Caldara R, Castiglioni MT, et al. Pregnancy after pancreas-kidney transplantation. J Nephrol 2020; 33:1009.</a></li><li><a class="nounderline abstract_t">Tang J, Gulyani A, Hewawasam E, et al. Pregnancy outcomes for simultaneous Pancreas-Kidney transplant recipients versus kidney transplant recipients. Clin Transplant 2021; 35:e14151.</a></li><li><a class="nounderline abstract_t">Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233:463.</a></li><li><a class="nounderline abstract_t">Douzdjian V, Ferrara D, Silvestri G. Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness decision analysis model. Am J Kidney Dis 1998; 31:794.</a></li><li><a class="nounderline abstract_t">Cohn JA, Englesbe MJ, Ads YM, et al. Financial implications of pancreas transplant complications: a business case for quality improvement. Am J Transplant 2007; 7:1656.</a></li><li class="breakAll">Gruessner AC, Sutherland DE. Pancreas transplants for United States (US) and non-US cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). In: Clinical Transplants 1997, Cecka JM, Terasaki PI (Eds), UCLA Tissue Typing Laboratory, Los Angeles 1998.</li><li><a class="nounderline abstract_t">Newell KA, Woodle ES, Millis JM, et al. Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function. Transplant Proc 1995; 27:3002.</a></li><li><a class="nounderline abstract_t">Monroy-Cuadros M, Salazar A, Yilmaz S, McLaughlin K. Bladder vs enteric drainage in simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 2006; 21:483.</a></li><li><a class="nounderline abstract_t">King EA, Kucirka LM, McAdams-DeMarco MA, et al. Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation: Patient and Center-Level Factors. Am J Transplant 2016; 16:541.</a></li><li><a class="nounderline abstract_t">Gruessner RW, Gruessner AC. The current state of pancreas transplantation. Nat Rev Endocrinol 2013; 9:555.</a></li><li><a class="nounderline abstract_t">Gruessner RW, Gruessner AC. Pancreas transplant alone: a procedure coming of age. Diabetes Care 2013; 36:2440.</a></li><li><a class="nounderline abstract_t">Gruessner AC, Gruessner RW. Pancreas Transplantation of US and Non-US Cases from 2005 to 2014 as Reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud 2016; 13:35.</a></li><li><a class="nounderline abstract_t">Kandaswamy R, Stock PG, Gustafson SK, et al. OPTN/SRTR 2016 Annual Data Report: Pancreas. Am J Transplant 2018; 18 Suppl 1:114.</a></li><li><a class="nounderline abstract_t">Grochowiecki T, Gałązka Z, Madej K, et al. Multivariate analysis of complications after simultaneous pancreas and kidney transplantation. Transplant Proc 2014; 46:2806.</a></li><li><a class="nounderline abstract_t">Manrique A, Jiménez C, López RM, et al. Relaparotomy after pancreas transplantation: causes and outcomes. Transplant Proc 2009; 41:2472.</a></li><li><a class="nounderline abstract_t">Laftavi MR, Gruessner A, Gruessner R. Surgery of pancreas transplantation. Curr Opin Organ Transplant 2017; 22:389.</a></li><li><a class="nounderline abstract_t">Banga N, Hadjianastassiou VG, Mamode N, et al. Outcome of surgical complications following simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 2012; 27:1658.</a></li><li><a class="nounderline abstract_t">Redfield RR, Rickels MR, Naji A, Odorico JS. Pancreas Transplantation in the Modern Era. Gastroenterol Clin North Am 2016; 45:145.</a></li><li><a class="nounderline abstract_t">Sharda B, Jay CL, Gurung K, et al. Improved surgical outcomes following simultaneous pancreas-kidney transplantation in the contemporary era. Clin Transplant 2022; 36:e14792.</a></li><li><a class="nounderline abstract_t">Troppmann C. Complications after pancreas transplantation. Curr Opin Organ Transplant 2010; 15:112.</a></li><li><a class="nounderline abstract_t">Page M, Rimmelé T, Ber CE, et al. Early relaparotomy after simultaneous pancreas-kidney transplantation. Transplantation 2012; 94:159.</a></li><li><a class="nounderline abstract_t">Goodman J, Becker YT. Pancreas surgical complications. Curr Opin Organ Transplant 2009; 14:85.</a></li><li><a class="nounderline abstract_t">Humar A, Kandaswamy R, Granger D, et al. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000; 231:269.</a></li><li><a class="nounderline abstract_t">Kopp WH, van Leeuwen CAT, Lam HD, et al. Retrospective study on detection, treatment, and clinical outcome of graft thrombosis following pancreas transplantation. Transpl Int 2019; 32:410.</a></li><li><a class="nounderline abstract_t">Muthusamy AS, Giangrande PL, Friend PJ. Pancreas allograft thrombosis. Transplantation 2010; 90:705.</a></li><li><a class="nounderline abstract_t">Farney AC, Rogers J, Stratta RJ. Pancreas graft thrombosis:  causes, prevention, diagnosis, and intervention. Curr Opin Organ Transplant 2012; 17:87.</a></li><li><a class="nounderline abstract_t">El-Hennawy H, Stratta RJ, Smith F. Exocrine drainage in vascularized pancreas transplantation in the new millennium. World J Transplant 2016; 6:255.</a></li><li><a class="nounderline abstract_t">Rudolph EN, Dunn TB, Sutherland DER, et al. Optimizing outcomes in pancreas transplantation: Impact of organ preservation time. Clin Transplant 2017; 31.</a></li><li><a class="nounderline abstract_t">Stratta RJ, Farney AC, Fridell JA. Analyzing outcomes following pancreas transplantation: Definition of a failure or failure of a definition. Am J Transplant 2022; 22:1523.</a></li><li class="breakAll">SRTR/OPTN report data. Unadjusted graft and patient survival at 3 months, 1, 3, 5, and 10 years. http://www.srtr.org/annual_reports/2011/113_dh.pdf (Accessed on June 03, 2015).</li><li><a class="nounderline abstract_t">Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19:433.</a></li><li><a class="nounderline abstract_t">Finger EB, Radosevich DM, Dunn TB, et al. A composite risk model for predicting technical failure in pancreas transplantation. Am J Transplant 2013; 13:1840.</a></li><li><a class="nounderline abstract_t">Ziaja J, Król R, Pawlicki J, et al. Donor-dependent risk factors for early surgical complications after simultaneous pancreas-kidney transplantation. Transplant Proc 2011; 43:3092.</a></li><li><a class="nounderline abstract_t">Humar A, Ramcharan T, Kandaswamy R, et al. Technical failures after pancreas transplants: why grafts fail and the risk factors--a multivariate analysis. Transplantation 2004; 78:1188.</a></li><li><a class="nounderline abstract_t">Fridell JA, Rogers J, Stratta RJ. The pancreas allograft donor: current status, controversies, and challenges for the future. Clin Transplant 2010; 24:433.</a></li><li><a class="nounderline abstract_t">Axelrod DA, Sung RS, Meyer KH, et al. Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization. Am J Transplant 2010; 10:837.</a></li><li><a class="nounderline abstract_t">Alhamad T, Malone AF, Lentine KL, et al. Selected Mildly Obese Donors Can Be Used Safely in Simultaneous Pancreas and Kidney Transplantation. Transplantation 2017; 101:1159.</a></li><li><a class="nounderline abstract_t">Gruessner RW, Dunn DL, Gruessner AC, et al. Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. Transplantation 1994; 57:1598.</a></li><li><a class="nounderline abstract_t">Gurung K, Alejo J, Rogers J, et al. Recipient age and outcomes following simultaneous pancreas-kidney transplantation in the new millennium: Single-center experience and review of the literature. Clin Transplant 2021; 35:e14302.</a></li><li class="breakAll">www.med.umn.edu/IPTR/annual_reports/2003_annual (Accessed on August 08, 2005).</li><li><a class="nounderline abstract_t">Siskind E, Maloney C, Akerman M, et al. An analysis of pancreas transplantation outcomes based on age groupings--an update of the UNOS database. Clin Transplant 2014; 28:990.</a></li><li><a class="nounderline abstract_t">Laurence JM, Marquez MA, Seal JB, et al. The effect of recipient age on outcome after pancreas transplantation. Transplantation 2015; 99:e13.</a></li><li><a class="nounderline abstract_t">Mittal S, Smilevska R, Franklin R, et al. An analysis of the association between older recipient age and outcomes after whole-organ pancreas transplantation - a single-centre, retrospective study. Transpl Int 2020; 33:529.</a></li><li><a class="nounderline abstract_t">Scalea JR, Redfield RR 3rd, Arpali E, et al. Pancreas transplantation in older patients is safe, but patient selection is paramount. Transpl Int 2016; 29:810.</a></li><li><a class="nounderline abstract_t">Sampaio MS, Reddy PN, Kuo HT, et al. Obesity was associated with inferior outcomes in simultaneous pancreas kidney transplant. Transplantation 2010; 89:1117.</a></li><li><a class="nounderline abstract_t">Owen RV, Thompson ER, Tingle SJ, et al. Too Fat for Transplant? The Impact of Recipient BMI on Pancreas Transplant Outcomes. Transplantation 2021; 105:905.</a></li><li><a class="nounderline abstract_t">Luan FL, Kommareddi M, Cibrik DM, et al. Influence of recipient race on the outcome of simultaneous pancreas and kidney transplantation. Am J Transplant 2010; 10:2074.</a></li><li><a class="nounderline abstract_t">Brooks JT, Liu R, Oliver M, et al. Simultaneous Pancreas and Kidney Transplantation is Associated With Inferior Long-Term Outcomes in African Americans. Pancreas 2018; 47:116.</a></li><li><a class="nounderline abstract_t">Zhang R, Florman S, Devidoss S, et al. A comparison of long-term survivals of simultaneous pancreas-kidney transplant between African American and Caucasian recipients with basiliximab induction therapy. Am J Transplant 2007; 7:1815.</a></li><li><a class="nounderline abstract_t">Young CJ, MacLennan PA, Mannon EC, et al. Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center Experience. Ann Surg 2020; 271:177.</a></li><li><a class="nounderline abstract_t">Rogers J, Jay CL, Farney AC, et al. Simultaneous pancreas-kidney transplantation in Caucasian versus African American patients: Does recipient race influence outcomes? Clin Transplant 2022; 36:e14599.</a></li><li><a class="nounderline abstract_t">Ricart MJ, Malaise J, Moreno A, et al. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 2005; 20 Suppl 2:ii25.</a></li><li><a class="nounderline abstract_t">Lo A, Stratta RJ, Egidi MF, et al. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl Infect Dis 2001; 3:8.</a></li><li><a class="nounderline abstract_t">Stratta RJ, Alloway RR, Lo A, et al. Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients. Transplant Proc 2004; 36:1082.</a></li><li><a class="nounderline abstract_t">Stratta RJ, Thacker LR, Sundberg AK, South-Eastern Organ Procurement Foundation. Multivariate analysis of the influence of donor and recipient cytomegalovirus sero-pairing on outcomes in simultaneous kidney-pancreas transplantation: the South-Eastern Organ Procurement Foundation Experience. Transplant Proc 2005; 37:1271.</a></li><li><a class="nounderline abstract_t">Lipshutz GS, Mahanty H, Feng S, et al. BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant. Am J Transplant 2005; 5:366.</a></li><li><a class="nounderline abstract_t">Robertson RP. Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes 1986; 35:1016.</a></li><li><a class="nounderline abstract_t">Nielsen JH, Mandrup-Poulsen T, Nerup J. Direct effects of cyclosporin A on human pancreatic beta-cells. Diabetes 1986; 35:1049.</a></li><li><a class="nounderline abstract_t">Robertson RP. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 2004; 350:694.</a></li><li><a class="nounderline abstract_t">Sibley RK, Sutherland DE, Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985; 53:132.</a></li><li><a class="nounderline abstract_t">Tydén G, Reinholt FP, Sundkvist G, Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996; 335:860.</a></li><li><a class="nounderline abstract_t">Burke GW 3rd, Vendrame F, Virdi SK, et al. Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity. Curr Diab Rep 2015; 15:121.</a></li><li><a class="nounderline abstract_t">Guerra G, Indahyung R, Bucci CM, et al. Elevated incidence of posttransplant erythrocytosis after simultaneous pancreas kidney transplantation. Am J Transplant 2010; 10:938.</a></li><li><a class="nounderline abstract_t">Humar A, Johnson EM, Gillingham KJ, et al. Venous thromboembolic complications after kidney and kidney-pancreas transplantation: a multivariate analysis. Transplantation 1998; 65:229.</a></li><li><a class="nounderline abstract_t">Choi JY, Jung JH, Kwon HW, et al. Does Enteric Conversion Affect Graft Survival After Pancreas Transplantation with Bladder Drainage? Ann Transplant 2018; 23:89.</a></li><li><a class="nounderline abstract_t">Riad SM, Keys DO, Jackson S, et al. Enteric Conversion of Bladder-drained Pancreas as a Predictor of Outcomes in Almost 600 Recipients at a Single Center. Transplant Direct 2020; 6:e550.</a></li><li><a class="nounderline abstract_t">Adler JT, Zaborek N, Redfield RR 3rd, et al. Enteric conversion after bladder-drained pancreas transplantation is not associated with worse allograft survival. Am J Transplant 2019; 19:2543.</a></li></ol></div><div id="topicVersionRevision">Topic 7313 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35266622" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : OPTN/SRTR 2020 Annual Data Report: Pancreas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25565444" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Simultaneous pancreas and kidney transplantation: current trends and future directions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14657065" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Survival after pancreas transplantation in patients with diabetes and preserved kidney function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31801788" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Superior Long-term Survival for Simultaneous Pancreas-Kidney Transplantation as Renal Replacement Therapy: 30-Year Follow-up of a Nationwide Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25757212" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25629390" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Survival benefit of solid-organ transplant in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32578221" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Relative survival and quality of life benefits of pancreas-kidney transplantation, deceased kidney transplantation and dialysis in type 1 diabetes mellitus-a probabilistic simulation model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23512107" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Mortality in diabetes: pancreas transplantation is associated with significant survival benefit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19131460" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Incremental value of the pancreas allograft to the survival of simultaneous pancreas-kidney transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31628870" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Outcomes after simultaneous kidney-pancreas versus pancreas after kidney transplantation in the current era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28319322" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : An analysis of the survival outcomes of simultaneous pancreas and kidney transplantation compared to live donor kidney transplantation in patients with type 1 diabetes: a UK Transplant Registry study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30188614" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The survival advantage of pancreas after kidney transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15575904" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Mortality assessment for pancreas transplants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33992729" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Transplant Options for Patients With Diabetes and Advanced Kidney Disease: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26713324" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33131111" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Early technical pancreas failure in Simultaneous Pancreas-Kidney Recipients does not impact renal allograft outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34362019" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Impact of Early Pancreatic Graft Loss on Outcome after Simultaneous Pancreas-Kidney Transplantation (SPKT)-A Landmark Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1858159" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Long-term metabolic and quality of life results with pancreatic/renal transplantation in insulin-dependent diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11675431" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Simultaneous pancreas-kidney and pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9000702" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1797502" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Hypoglycemia after successful pancreas transplantation in type I diabetic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19674015" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Quality of life in simultaneous pancreas-kidney transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20176426" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Prospective quality-of-life monitoring of simultaneous pancreas and kidney transplant recipients using the 36-item short form health survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25581297" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Health-related quality of life may improve after transplantation in pancreas-kidney recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31246747" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Quality of life after pancreas transplantation: time to look again.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31794062" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The quality of life in type I diabetic patients with end-stage kidney disease before and after simultaneous pancreas-kidney transplantation: a single-center prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32562558" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Changes in quality of life, health status and other patient-reported outcomes following simultaneous pancreas and kidney transplantation (SPKT): a quantitative and qualitative analysis within a UK-wide programme.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32548246" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Psychological Symptoms and Quality of Life After Simultaneous Kidney and Pancreas Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30393905" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Health-related quality of life following kidney and simultaneous pancreas kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32912255" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Impact of pre-transplant dialysis modality on the outcome and health-related quality of life of patients after simultaneous pancreas-kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9686331" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Quality of life after pancreas transplantation: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12955671" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Quality of life after kidney and pancreas transplantation: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12955671" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Quality of life after kidney and pancreas transplantation: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12955671" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Quality of life after kidney and pancreas transplantation: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9654536" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Reversal of lesions of diabetic nephropathy after pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9392572" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Long-term effects of pancreatic transplantation on diabetic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11978689" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11202576" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24316760" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Life after pancreas transplantation: reversal of diabetic lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32903964" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Impact of Functional Status on Outcomes of Simultaneous Pancreas-kidney Transplantation: Risks and Opportunities for Patient Benefit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28598888" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Long-term diabetes complications after pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23283247" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Follow-up of secondary diabetic complications after pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34245223" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : First World Consensus Conference on pancreas transplantation: Part II - recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21441123" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29735033" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Pancreas Transplantation for Patients with Type 1 and Type 2 Diabetes Mellitus in the United States: A Registry Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29916848" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Pancreas transplantation in type 2 diabetes: expanding the criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25667140" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pancreas transplantation in C-peptide positive patients: does "type" of diabetes really matter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31251417" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Comparison of glycemic control after pancreas transplantation for Type 1 and Type 2 diabetic recipients at a high volume center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28478590" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Simultaneous Pancreas and Kidney Transplantation-Is It a Treatment Option for Patients With Type 2 Diabetes Mellitus? An Analysis of the International Pancreas Transplant Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34279713" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Simultaneous pancreas and kidney transplantation for end-stage kidney disease patients with type 2 diabetes mellitus: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33350048" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Single center results of simultaneous pancreas-kidney transplantation in patients with type 2 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35576270" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Pancreas Transplantation for Type 2 Diabetes: A Systematic Review, Critical Gaps in the Literature, and a Path Forward.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31553823" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Three-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation in type 2 diabetes patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17700161" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Risk factors for mortality in diabetic nephropathy patients accepted for transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11703616" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16613593" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Kidney and pancreas transplantation in the United States, 1995-2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17060846" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The long-term management of pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10371569" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10792634" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12552511" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15614154" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Long-term follow-up of 78 simultaneous pancreas-kidney transplants at a single-center institution in Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10096516" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10714635" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12506153" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19730242" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19201918" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19406961" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20047608" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Transplantation with pancreas after living donor kidney vs. living donor kidney alone in type 1 diabetes mellitus recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15332226" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20093348" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15643998" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16641596" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Preemptive versus Non-preemptive simultaneous pancreas-kidney transplantation: a single-center, long-term, follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32479673" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Outcomes of simultaneous pancreas and kidney transplants based on preemptive transplant compared to those who were on dialysis before transplant - a retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32479673" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Outcomes of simultaneous pancreas and kidney transplants based on preemptive transplant compared to those who were on dialysis before transplant - a retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31568218" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : More Than 25 Years of Pancreas Graft Survival After Simultaneous Pancreas and Kidney Transplantation: Experience From the World's Largest Series of Long-term Survivors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2185105" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2253832" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2254456" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8168643" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1448124" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Seminars in medicine of the Beth Israel Hospital, Boston: Pancreatic and islet transplantation for diabetes--cures or curiosities?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9035608" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Metabolic characterization of long-term successful pancreas transplants in type I diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14988247" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Consequences on beta-cell function and reserve after long-term pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32106853" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Short and long-term metabolic outcomes in patients with type 1 and type 2 diabetes receiving a simultaneous pancreas kidney allograft.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27336397" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Long-term Metabolic Outcomes of Functioning Pancreas Transplants in Type 2 Diabetic Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31545535" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Continuous glucose monitoring to assess glycemic control in the first 6 weeks after pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11435965" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Prediction of the long-term metabolic success of the pancreatic graft function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1737540" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Lipid status after pancreas-kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8133660" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Effects of systemic delivery of insulin on plasma lipids and lipoprotein concentrations in pancreas transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33660656" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Impact of Simultaneous Pancreas-kidney Transplantation on Cardiovascular Risk in Patients With Diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16101726" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31815616" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Effects of simultaneous pancreas-kidney transplantation and kidney transplantation alone on the outcome of peripheral vascular diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2659996" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7901527" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33909390" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Treating Type 1 Diabetes by Pancreas Transplant Alone: A Cohort Study on Actual Long-term (10 Years) Efficacy and Safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25145544" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15920053" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : The beneficial effects of pancreas transplant alone on diabetic nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2320063" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Effects of pancreatic transplantation on diabetic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2354747" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9089222" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Diabetic neuropathy after pancreas transplantation: determinants of recovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1989326" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Effect of successful renal and segmental pancreatic transplantation on peripheral and autonomic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1989324" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Improvement in autonomic function following combined pancreas-kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16226599" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Early detection of diabetic peripheral neuropathy with corneal confocal microscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20435796" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12488951" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Diabetic retinopathyA clinical update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12941734" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1936707" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Diabetic retinopathy and pancreas transplantation: a 3-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3275895" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8008349" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy. A case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2326028" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Progression of diabetic retinopathy after pancreas transplantation. The University of Michigan Pancreas Transplant Evaluation Committee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1936704" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Does pancreas transplantation influence the course of diabetic retinopathy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10873985" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Stabilisation of diabetic retinopathy following simultaneous pancreas and kidney transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15819813" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Effects of pancreas-kidney transplantation on diabetic retinopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28968353" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Long-term Effects of Pancreas Transplantation on Diabetic Retinopathy and Incidence and Predictive Risk Factors for Early Worsening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32301225" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Early worsening of diabetic retinopathy after simultaneous pancreas and kidney transplantation-Myth or reality?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23283136" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23446255" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Choices in kidney transplantation in type 1 diabetes: are there skeletal benefits of the endocrine pancreas?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34292634" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Outcomes of pregnancy in simultaneous pancreas and kidney transplant recipients: A single-center retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34933349" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Pregnancy After Simultaneous Pancreas-Kidney Transplantation in Treatment of End-Stage Diabetes Mellitus: a Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32959341" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Pregnancy after pancreas-kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33179349" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Pregnancy outcomes for simultaneous Pancreas-Kidney transplant recipients versus kidney transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11303130" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Lessons learned from more than 1,000 pancreas transplants at a single institution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9590189" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness decision analysis model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17425623" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Financial implications of pancreas transplant complications: a business case for quality improvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17425623" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Financial implications of pancreas transplant complications: a business case for quality improvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8539812" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16286430" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Bladder vs enteric drainage in simultaneous pancreas-kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26474070" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation: Patient and Center-Level Factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23897173" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : The current state of pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23881967" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Pancreas transplant alone: a procedure coming of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26982345" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Pancreas Transplantation of US and Non-US Cases from 2005 to 2014 as Reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29292605" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : OPTN/SRTR 2016 Annual Data Report: Pancreas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25380923" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Multivariate analysis of complications after simultaneous pancreas and kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19715955" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Relaparotomy after pancreas transplantation: causes and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28682797" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Surgery of pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21903603" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Outcome of surgical complications following simultaneous pancreas-kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26895686" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Pancreas Transplantation in the Modern Era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36029250" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Improved surgical outcomes following simultaneous pancreas-kidney transplantation in the contemporary era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20009931" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Complications after pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22728293" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Early relaparotomy after simultaneous pancreas-kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19337152" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Pancreas surgical complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10674620" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Decreased surgical risks of pancreas transplantation in the modern era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30525250" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Retrospective study on detection, treatment, and clinical outcome of graft thrombosis following pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20616765" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Pancreas allograft thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22186095" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Pancreas graft thrombosis:  causes, prevention, diagnosis, and intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27358771" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Exocrine drainage in vascularized pancreas transplantation in the new millennium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28636074" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Optimizing outcomes in pancreas transplantation: Impact of organ preservation time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35175669" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Analyzing outcomes following pancreas transplantation: Definition of a failure or failure of a definition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35175669" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Analyzing outcomes following pancreas transplantation: Definition of a failure or failure of a definition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16008587" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23711225" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : A composite risk model for predicting technical failure in pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21996234" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Donor-dependent risk factors for early surgical complications after simultaneous pancreas-kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15502718" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Technical failures after pancreas transplants: why grafts fail and the risk factors--a multivariate analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20384731" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : The pancreas allograft donor: current status, controversies, and challenges for the future.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20121753" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27428713" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Selected Mildly Obese Donors Can Be Used Safely in Simultaneous Pancreas and Kidney Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8009594" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33783874" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Recipient age and outcomes following simultaneous pancreas-kidney transplantation in the new millennium: Single-center experience and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33783874" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Recipient age and outcomes following simultaneous pancreas-kidney transplantation in the new millennium: Single-center experience and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24954160" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : An analysis of pancreas transplantation outcomes based on age groupings--an update of the UNOS database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25651123" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : The effect of recipient age on outcome after pancreas transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31943392" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : An analysis of the association between older recipient age and outcomes after whole-organ pancreas transplantation - a single-centre, retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26859581" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Pancreas transplantation in older patients is safe, but patient selection is paramount.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20164819" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Obesity was associated with inferior outcomes in simultaneous pancreas kidney transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33741849" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Too Fat for Transplant? The Impact of Recipient BMI on Pancreas Transplant Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20645942" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Influence of recipient race on the outcome of simultaneous pancreas and kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29215537" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Simultaneous Pancreas and Kidney Transplantation is Associated With Inferior Long-Term Outcomes in African Americans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17524073" id="rid166" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>167 : A comparison of long-term survivals of simultaneous pancreas-kidney transplant between African American and Caucasian recipients with basiliximab induction therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29781845" id="rid167" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>168 : Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35044001" id="rid168" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>169 : Simultaneous pancreas-kidney transplantation in Caucasian versus African American patients: Does recipient race influence outcomes?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15814546" id="rid169" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>170 : Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11429034" id="rid170" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>171 : Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15194376" id="rid171" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>172 : Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15848692" id="rid172" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>173 : Multivariate analysis of the influence of donor and recipient cytomegalovirus sero-pairing on outcomes in simultaneous kidney-pancreas transplantation: the South-Eastern Organ Procurement Foundation Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15643997" id="rid173" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>174 : BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3527823" id="rid174" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>175 : Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3527825" id="rid175" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>176 : Direct effects of cyclosporin A on human pancreatic beta-cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14960745" id="rid176" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>177 : Islet transplantation as a treatment for diabetes - a work in progress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3894793" id="rid177" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>178 : Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8778604" id="rid178" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>179 : Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26547222" id="rid179" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>180 : Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20148815" id="rid180" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>181 : Elevated incidence of posttransplant erythrocytosis after simultaneous pancreas kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9458020" id="rid181" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>182 : Venous thromboembolic complications after kidney and kidney-pancreas transplantation: a multivariate analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29391389" id="rid182" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>183 : Does Enteric Conversion Affect Graft Survival After Pancreas Transplantation with Bladder Drainage?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32548244" id="rid183" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>184 : Enteric Conversion of Bladder-drained Pancreas as a Predictor of Outcomes in Almost 600 Recipients at a Single Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30838785" id="rid184" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>185 : Enteric conversion after bladder-drained pancreas transplantation is not associated with worse allograft survival.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
